Back to BCRX

Kynam Capital Management, LP → BCRX

Kynam Capital Management, LP BCRX Position History

BioCryst Pharmaceuticals, Inc. • Healthcare

Quarters held
4
Latest value
$21M
Q3 2026
Peak value
$73.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$73.1M
Q1 2026$54.1M
Q2 2026$25.2M
Q3 2026$21M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$21M2.52M——
Q2 2026$25.2M2.52M——
Q1 2026$54.1M5.68M——
Q4 2025$73.1M9.37M——

Other funds holding BCRX

Other Kynam Capital Management, LP positions

COGT

COGENT BIOSCIENCES INC

$219M
CLDX

CELLDEX THERAPEUTICS INC NEW

$198.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$188.1M
CLDX

CELLDEX THERAPEUTICS INC NEW

$185.3M
LEGN

LEGEND BIOTECH CORP

$182.1M
SNDX

SYNDAX PHARMACEUTICALS INC

$176M
VERA

VERA THERAPEUTICS INC

$173.8M
PCVX

VAXCYTE INC

$169.9M